BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan B, Lian J, Deng C. Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats. J Psychopharmacol 2018;32:1252-63. [PMID: 30136620 DOI: 10.1177/0269881118788822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Lian J, Deng C. Early antipsychotic exposure affects NMDA and GABAA receptor binding in the brains of juvenile rats. Psychiatry Res 2019;273:739-45. [PMID: 31207861 DOI: 10.1016/j.psychres.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat 2019;15:2559-69. [PMID: 31564881 DOI: 10.2147/NDT.S209284] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
3 Pan B, Wang Y, Shi Y, Yang Q, Han B, Zhu X, Liu Y. Altered expression levels of miR-144-3p and ATP1B2 are associated with schizophrenia. World J Biol Psychiatry 2022;:1-11. [PMID: 34989308 DOI: 10.1080/15622975.2021.2022757] [Reference Citation Analysis]
4 Sabe M, Zhao N, Crippa A, Kaiser S. Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials. NPJ Schizophr 2021;7:43. [PMID: 34518532 DOI: 10.1038/s41537-021-00171-2] [Reference Citation Analysis]